Low glycemic diet does not improve risk factors for cardiovascular disease and diabetes
- Details
- Category: Research
Nutrition experts are continually debating the nutritional value of carbohydrate-containing foods and whether some are healthier than others. High carbohydrate foods are classified by how much they increase blood sugar; known as glycemic index. In new findings led by researchers at Brigham and Women's Hospital (BWH) in Boston and Johns Hopkins University (JHU) in Baltimore, researchers looked at
New targeted drugs could treat drug-resistant skin cancer
- Details
- Category: Research
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports. Clinical trials to test the new drugs in patients should begin as early as 2015. Existing drugs target faulty versions of a protein called BRAF which drives about half of all melanomas, but while initially very effective, the cancers almost always become resistant to treatment within a year.
Injectable 3D vaccines could fight cancer and infectious diseases
- Details
- Category: Research
One of the reasons cancer is so deadly is that it can evade attack from the body's immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences (SEAS) show a non-surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV.
Can researchers develop 100 drugs in 10 years?
- Details
- Category: Research
Develop 100 drugs in 10 years. That's the ambitious goal set by a group of scientists and engineers at the University of Utah, founders of Recursion Pharmaceuticals, a start-up company that is able to quickly and affordably identify unexpected ways a drug could be used by testing it on diseased cells.
Study shows new kind of targeted drug has promise for leukemia patients
- Details
- Category: Research
A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented at the 56th Annual Meeting of the American Society of Hematology.
Top-selling eye vitamins found not to match scientific evidence
- Details
- Category: Research
With Americans spending billions of dollars each year on nutritional supplements, researchers have analyzed popular eye vitamins to determine whether their formulations and claims are consistent with scientific findings. They determined that some of the top-selling products do not contain identical ingredient dosages to eye vitamin formulas proven effective in clinical trials.
How to create and sustain clinical-research partnerships
- Details
- Category: Research
Pragmatic clinical trials - real-life tests done in real-world settings - are increasingly important for answering pressing questions about how best to deliver health care. But these pragmatic trials require close collaboration between two professional groups who often have contrasting styles. One group is researchers, who follow structure like classical musicians.
More Pharma News ...
- New study strengthens evidence of the connection between statin use and cataracts
- Breast cancer vaccine shows promise in small clinical trial
- NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response
- Vegetable oil ingredient key to destroying gastric disease bacteria
- Another reason to be thankful: turkeys may be lifesavers
- Muscle relaxant may be viable treatment for rare form of diabetes
- Only half of patients take their medications as prescribed